You are here

  • Home
  • Archive
  • Volume 55, Issue 10
  • Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

Citation Tools

Article menu
Download PDFPDF
Research Article
Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Peeters HR, Jongen-Lavrencic M, Vreugdenhil G, et al
Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.
Annals of the Rheumatic Diseases 1996;55:739-744.